Keyphrases
Multiple Myeloma
100%
B-cell Acute Lymphoblastic Leukemia (B-ALL)
100%
Clonal Identity
100%
Lenalidomide
40%
TP53 Variants
40%
Rare Cells
20%
Immunoglobulin Heavy Chain
20%
Tumor
10%
Fluorescence in Situ Hybridization
10%
Whole Exome Sequencing
10%
TP53 mutation
10%
Cell Population
10%
Mutated Genes
10%
Paired Samples
10%
Acute Myeloid Leukemia
10%
Bone Marrow
10%
Malignancy
10%
Malignant Transformation
10%
Immunohistochemical Staining
10%
Clonal Hematopoiesis
10%
Fluorescence in Situ Hybridization Analysis
10%
Patient Samples
10%
Myeloma Cells
10%
Tumor Protein p53 (TP53)
10%
Variant Allele Frequency
10%
Treatment-related
10%
Recurrent Variants
10%
Second Malignancy
10%
Clonality Assessment
10%
Biological Relationships
10%
Clonal Relationship
10%
Sequencing Depth
10%
TP53 mutant
10%
Founding Population
10%
Common Path
10%
Cell-average
10%
Medicine and Dentistry
Multiple Myeloma
100%
Acute B-Cell Lymphoblastic Leukemia
100%
Acute Lymphocytic Leukemia
100%
Lenalidomide
40%
Fluorescence in Situ Hybridization
20%
Immunoglobulin Heavy Chain
20%
Neoplasm
10%
Cancer
10%
Acute Myeloid Leukemia
10%
Malignant Transformation
10%
Hematopoiesis
10%
Clonal Variation
10%
Second Cancer
10%
Exome Sequencing
10%
Gene Frequency
10%
Immunology and Microbiology
Multiple Myeloma
100%
B Cell
100%
Lenalidomide
40%
Fluorescence in Situ Hybridization
20%
Immunoglobulin Heavy Chain
20%
Myeloid
10%
Whole Exome Sequencing
10%
Clonal Variation
10%
Hematopoiesis
10%
Myeloma Cell
10%
Gene Frequency
10%
Biochemistry, Genetics and Molecular Biology
B Cell
100%
Fluorescence in Situ Hybridization
20%
Heavy Chain
20%
Intravenous Immunoglobulin
20%
Cytogenetics
20%
Exome Sequencing
10%
Gene Frequency
10%
Mutated Genes
10%
Myeloid
10%
Clonality
10%
Clonal Variation
10%
Malignant Transformation
10%
Hematopoiesis
10%